Chris Halyk

Director/Board Member at MEDIPHARM LABS CORP.

Net worth: 4 988 $ as of 30/05/2024

Commercial Services

Health Technology

Process Industries

Profile

Chris Halyk is an Independent Director at MediPharm Labs Corp.
He previously worked as a Managing Director at Ortho Biotech, Inc., a Director at Innovative Medicines Canada, and as the President at Janssen, Inc. Mr. Halyk completed his undergraduate degree at Richard Ivey School of Business.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
MEDIPHARM LABS CORP. 0.02%	21/12/2023	86,000 ( 0.02% )	4 988 $	30/05/2024

Chris Halyk active positions

Companies	Position	Start
MEDIPHARM LABS CORP.	Director/Board Member	03/08/2020

All active positions of Chris Halyk

Former positions of Chris Halyk

Companies	Position	End
Janssen, Inc. Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada.	President	31/12/2018
Innovative Medicines Canada Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada.	Director/Board Member	31/12/2012
Ortho Biotech, Inc.	Corporate Officer/Principal	-

See the detail of Chris Halyk's experience

Training of Chris Halyk

Richard Ivey School of Business

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Chris Halyk's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
MEDIPHARM LABS CORP.	Process Industries

Private companies	3
Innovative Medicines Canada Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada.	Commercial Services
Janssen, Inc. Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada.	Health Technology
Ortho Biotech, Inc.

See company connections